Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-22

Clinical Trial Update: Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing azacitidine versus conventional chemotherapy as consolidation therapy in elderly patients with acute myeloid leukemia has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIDAZA (AZACITIDINE)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED